|
Emmett Velten, Ph.D. is the Methadone has Research Prejudice
|
The Emotion Some Numerous In At |
|
Emmett Velten, Ph.D. is the Methadone has Research Prejudice
|
The Emotion Some Numerous In At |
On the Invitational Conference on Drug User Activism Sponsored by the Danish Drug Users Union (BrugerForeningen) and Dutch National Interest Group of Drug Users (Landelijk Steunpunt Druggebruikers 2003, October 31st/November 1st Copenhagen, Denmark Howard S. Lotsof Board of Directors NAMA President, Dora Weiner Foundation http://www.doraweiner.org Submitted 27 November 2003 I came to be informed of…
Tennessee/NW Georgia Chapter of the National Alliance for Medication Assisted Recovery And we believe in the 5 goals of NAMA-R: To eliminate discrimination toward methadone patients. To create a more positive image about methadone maintenance treatment. To help preserve patient’s dignity and their rights. To make treatment available on demand to every person who needs…
Policy Statement Number 9 August 2002 There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration…
DOJ publishes guidance on Opioid Use Disorder and the Americans with Disabilities Act April 15, 2022 “The opioid crisis poses an extraordinary challenge to communities throughout our country. The Department of Justice (the Department) has responded with a comprehensive approach prioritizing prevention, enforcement, and treatment. This includes enforcing the Americans with Disabilities Act (Ada), which…
HCV Info Fact 24 August 2003 The risk factors for Hepatitis C Virus infection are: Intravenous drug use- Current or remote intravenous drug use accounts for 50% of new cases of HVC; 50% to 60% infected with HCV within 3 months of initiation of injection behavior Intranasal cocaine- Risk factor suggested by epidemiologic evidence Tattooing…
Issues To Focus On LAAM Manufacture to Be Discontinued August 23, 2003 Washington, D.C. Roxanne the manufacturer of LAAM has informed the FDA that manufacture of the medication is being discontinued. Distribution will continue until the inventory is depleted. Roxanne estimates this to be in early January 2004. The reason for the action is the…